Normal bone growth
Nutrient attribution: Vitamin D
“Vitamin D is needed for normal growth and development of bone in children”
Child-specific · EU legal wording ↗
Keep this boundary: No promise of extra height, faster growth or fracture prevention.
Nine products · Three clear benefit roles
A simpler positioning proposal built around bones, teeth, immunity, movement, cognitive function and normal energy release. Each icon is tied to a specific nutrient role and an EU-authorised claim.
Each SKU has three different roles. Some roles recur across products because the nutrients share authorised functions. This version follows the revised direction: parent relevance takes priority over forcing 27 unique benefits.
Vitamin D and D + K2 naturally overlap. Their ingredient composition distinguishes them; the table does not invent a superior growth benefit for the combination. The C + D + Zinc combination also does not imply greater immune protection.
The familiar shield, bone, tooth, arm, head and blood-cell motifs are illustration proposals. They must remain beside their qualifying text, without disease symbols, performance promises or regulatory approval badges.
The exact nutrient claim supports the short caption. Short captions are proposed copy and should accompany the specific nutrient claim; wording equivalence remains subject to review.
The simplest bone-growth story, with teeth and immune function as supporting roles.
Nutrient attribution: Vitamin D
“Vitamin D is needed for normal growth and development of bone in children”
Child-specific · EU legal wording ↗
Keep this boundary: No promise of extra height, faster growth or fracture prevention.
Nutrient attribution: Vitamin D
“Vitamin D contributes to the maintenance of normal teeth”
General function · EU legal wording ↗
Keep this boundary: Not a teething-pain or cavity-prevention claim.
Nutrient attribution: Vitamin D
“Vitamin D contributes to the normal function of the immune system in children.”
Child-specific · EU legal wording ↗
Keep this boundary: No claim to prevent colds, infections or other illnesses.
Age and positioning note: Bone-growth and immune claims are explicitly child-specific. This does not establish suitability of an unconfirmed infant dose.
Movement leads; normal nerve function and reduced tiredness complete the story.
Nutrient attribution: Magnesium
“Magnesium contributes to normal muscle function”
General function · EU legal wording ↗
Keep this boundary: Movement is a context, not a promise of better sport performance or earlier walking.
Nutrient attribution: Magnesium
“Magnesium contributes to normal functioning of the nervous system”
General function · EU legal wording ↗
Keep this boundary: No claims about calmness, sleep, behaviour or reaching milestones sooner.
Nutrient attribution: Magnesium
“Magnesium contributes to a reduction of tiredness and fatigue”
General function · EU legal wording ↗
Keep this boundary: Older-child positioning candidate. Not a reason to ignore persistent tiredness; not an infant sleep or energy claim.
Age and positioning note: This is a stronger older-child story. Do not force the same tiredness-led positioning onto 6–24-month drops.
An immune-led option with a clear food-related role and gum support.
Nutrient attribution: Vitamin C
“Vitamin C contributes to the normal function of the immune system”
General function · EU legal wording ↗
Keep this boundary: Do not turn a general claim into a claim of special importance for infants or infection prevention.
Nutrient attribution: Vitamin C
“Vitamin C increases iron absorption”
General function · EU legal wording ↗
Keep this boundary: Does not mean this product contains iron. No anaemia-treatment claim.
Nutrient attribution: Vitamin C
“Vitamin C contributes to normal collagen formation for the normal function of gums”
General function · EU legal wording ↗
Keep this boundary: Keep the collagen explanation with the caption. No teething-pain or gum-disease claim.
Age and positioning note: The gum caption needs the collagen explanation. General claims are not automatically cleared for the infant presentation.
Cognitive Support is the short caption for normal cognitive function.
Nutrient attribution: Zinc
“Zinc contributes to normal cognitive function”
General function · EU legal wording ↗
Keep this boundary: Use the short caption alongside the specific nutrient claim; wording equivalence remains subject to review. Prefer “Normal cognitive function” if equivalence is not accepted. No better grades, IQ, concentration or accelerated brain-development promise.
Nutrient attribution: Zinc
“Zinc contributes to the maintenance of normal skin”
General function · EU legal wording ↗
Keep this boundary: No claim to treat eczema, nappy rash, acne or wounds.
Nutrient attribution: Zinc
“Zinc contributes to the normal function of the immune system”
General function · EU legal wording ↗
Keep this boundary: No claim to prevent illness or uniquely improve children’s immunity.
Age and positioning note: The cognitive caption is provisional and especially relevant to older-child communication. It must not imply greater intelligence or infant cognitive development.
A recognisable energy-and-blood story, supported by normal nerve function.
Nutrient attribution: Vitamin B12
“Vitamin B12 contributes to normal energy-yielding metabolism”
General function · EU legal wording ↗
Keep this boundary: No instant energy, increased stamina or claim that the supplement supplies food energy.
Nutrient attribution: Vitamin B12
“Vitamin B12 contributes to normal red blood cell formation”
General function · EU legal wording ↗
Keep this boundary: No anaemia treatment, “builds blood” or correction of a diagnosed deficiency.
Nutrient attribution: Vitamin B12
“Vitamin B12 contributes to normal functioning of the nervous system”
General function · EU legal wording ↗
Keep this boundary: No memory, behaviour, learning-performance or developmental milestone claim.
Age and positioning note: Do not imply that every tired child needs B12, or that the product treats anaemia or a neurological condition.
Three familiar roles within one formulation; no claim of greater benefit than the individual nutrients.
Nutrient attribution: Vitamin D, Zinc and Vitamin C
“Vitamin D contributes to the normal function of the immune system in children.”
“Zinc contributes to the normal function of the immune system”
“Vitamin C contributes to the normal function of the immune system”
Child-specific D + general C/Zn · EU legal wording ↗ · 432/2012 for other named nutrients ↗
Keep this boundary: Each named nutrient must qualify independently. C and zinc wording is sourced to 432/2012. No “triple protection”, stronger immunity or blend-synergy claim.
Nutrient attribution: Vitamin D
“Vitamin D is needed for normal growth and development of bone in children”
Child-specific · EU legal wording ↗
Keep this boundary: No promise of extra height, faster growth or fracture prevention.
Nutrient attribution: Vitamin C
“Vitamin C contributes to the reduction of tiredness and fatigue”
General function · EU legal wording ↗
Keep this boundary: Older-child positioning candidate. Do not carry this message across to infant drops without age-specific assessment.
Age and positioning note: Reduced tiredness is an older-child candidate. For infant drops, only retain a caption after age and formulation review; three slots are not compulsory.
Bones lead, with normal teeth and muscle function as supporting roles.
Nutrient attribution: Vitamin D and Vitamin K
“Vitamin D is needed for normal growth and development of bone in children”
“Vitamin K contributes to the maintenance of normal bones”
Child-specific D + general K · EU legal wording ↗ · 432/2012 for other named nutrients ↗
Keep this boundary: Vitamin K wording is sourced to 432/2012. Do not change the authorised wording to K2-specific superiority or promise calcium direction away from arteries.
Nutrient attribution: Vitamin D
“Vitamin D contributes to the maintenance of normal teeth”
General function · EU legal wording ↗
Keep this boundary: Not a teething-pain or cavity-prevention claim.
Nutrient attribution: Vitamin D
“Vitamin D contributes to the maintenance of normal muscle function”
General function · EU legal wording ↗
Keep this boundary: No stronger muscles, enhanced coordination or faster motor-development promise.
Age and positioning note: Overlap with vitamin D is real. Differentiate through the actual D + K formulation, not an invented superior growth or calcium-routing claim.
The three benefit roles from the reference pack, supported by the corresponding nutrient claims.
Nutrient attribution: Iron
“Iron contributes to normal cognitive development of children”
Child-specific · EU legal wording ↗
Conditions of use: The food must qualify as at least a source of iron under the applicable legal conditions. Elemental iron per daily serving is not yet confirmed.
Keep this boundary: No promise of higher IQ, better school performance or faster development.
Nutrient attribution: Iron
“Iron contributes to normal formation of red blood cells and haemoglobin”
General function · EU legal wording ↗
Conditions of use: The food must qualify as at least a source of iron under the applicable legal conditions. Confirm the elemental iron amount and intended daily serving.
Keep this boundary: The full claim includes haemoglobin. Do not imply treatment or prevention of anaemia.
Nutrient attribution: Iron
“Iron contributes to normal energy-yielding metabolism”
General function · EU legal wording ↗
Conditions of use: The food must qualify as at least a source of iron under the applicable legal conditions. Confirm the elemental iron amount and intended daily serving.
Keep this boundary: No instant energy, extra stamina or promise that the supplement supplies food energy.
Age and positioning note: The cognitive-development claim explicitly refers to children; the blood-formation and energy claims are general-function claims. For drops (6–24 months) and suspension (24 months–12 years), confirm elemental iron per daily serving, age suitability and market requirements separately. These claims do not establish suitability of an unconfirmed infant dose or authorise an anaemia-treatment claim.
The three reference-pack roles, attributed specifically to DHA or EPA + DHA.
Nutrient attribution: DHA
“DHA contributes to maintenance of normal brain function”
General function · EU legal wording ↗
Conditions of use: At least 40 mg DHA per 100 g and per 100 kcal. Consumers must be informed that the beneficial effect is obtained with a daily intake of 250 mg DHA. Confirm DHA content separately from total oil content.
Keep this boundary: Maintenance of normal function is not accelerated brain development, improved learning or greater intelligence. Total fish-oil or omega-3 content is not the DHA amount.
Nutrient attribution: DHA
“DHA contributes to the maintenance of normal vision”
General function · EU legal wording ↗
Conditions of use: At least 40 mg DHA per 100 g and per 100 kcal. Consumers must be informed that the beneficial effect is obtained with a daily intake of 250 mg DHA.
Keep this boundary: No claim of sharper eyesight, correction of poor vision or screen protection. The separate infant visual-development claim has a different age limit and intake condition.
Nutrient attribution: EPA and DHA
“EPA and DHA contribute to the normal function of the heart”
General function · EU legal wording ↗
Conditions of use: The food must qualify as a source of EPA and DHA: at least 40 mg combined EPA + DHA per 100 g and per 100 kcal. Consumers must be informed that the beneficial effect is obtained with a daily intake of 250 mg EPA + DHA combined. Confirm both fatty acids in the formulation.
Keep this boundary: Do not apply this claim to an unconfirmed DHA-only or ALA-only formula. No prevention of heart disease, correction of heart defects or heart-development claim.
Age and positioning note: The three reference-pack claims are general-function claims, not infant-development claims. Assess the 6–24-month drops separately for 6–12 months and over 12–24 months; the separate DHA infant visual-development claim ends at 12 months. Neither drops nor the 24-month–12-year suspension is cleared until DHA and EPA quantities, age suitability and all claim conditions are confirmed. The intake figures shown describe claim conditions, not a recommended dose for a child.
Checked 13 September 2026. The official legal acts govern use. Iron and Omega 3 reference-pack roles are included as conditional proposals; adding them does not confirm eligibility of the final products.